Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI113871PMID 2910912PMCID PMC303673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Shear stress activation of platelet glycoprotein IIb/IIIa

  1989cited by this paper
• Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds.

  1988cited by this paper
• Exposure of binding sites for vitronectin on platelets following stimulation.

  1988cited by this paper
• The platelet membrane glycoprotein IIb-IIIa complex.

  1988cited by this paper
• Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation.

  1987influential reference
• The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets.

  1987cited by this paper
• Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease.

  1987cited by this paper
• Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients.

  1987cited by this paper
• THE ARG-GLY-ASP(SER) SEQUENCE OF FIBRONECTIN, AND THE GLYCOPROTEIN IIB-IIIA COMPLEX ARE NOT INVOLVED IN FIBRONECTIN DEPENDENT PLATELET ADHESION IN FLOW

  1987cited by this paper
• Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.

  1987cited by this paper
• A Preliminary Comparison of the Thrombogenic Activity of Vitronectin and Other RGD‐containing Proteins When Bound to Surfaces a

  1987cited by this paper
• Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.

  1987cited by this paper
• Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets.

  1987influential reference
• Platelet von Willebrand factor: evidence for its involvement in platelet adhesion to collagen.

  1987cited by this paper
• Effect of monoclonal antibodies against von Willebrand factor and platelet glycoproteins IIb/IIIa on the platelet retention test.

  1987cited by this paper
• Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.

  1987cited by this paper
• von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.

  1986cited by this paper
• Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

  1986cited by this paper
• Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads.

  1986cited by this paper
• von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation.

  1986cited by this paper
• The role of platelet membrane glycoproteins Ib and IIb‐IIIa in platelet adherence to human artery subendothelium

  1986cited by this paper
• The inhibitory effect of plasma fibronectin on collagen-induced platelet aggregation.

  1986cited by this paper
• Role of cp iib iiia as well as gpi b in von willebrand factor mediated platelet adhesion to collagen

  1986cited by this paper
• Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading.

  1986cited by this paper
• Rheological Aspects of Thrombosis and Haemostasis: Basic Principles and Applications

  1986cited by this paper
• Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.

  1986cited by this paper
• Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.

  1986cited by this paper
• Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules.

  1986influential reference
• Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.

  1986cited by this paper
• Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group.

  1985cited by this paper
• Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.

  1985influential reference
• Fibronectin in artery subendothelium is important for platelet adhesion.

  1985cited by this paper
• Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.

  1985cited by this paper
• Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.

  1985cited by this paper
• Extracellular matrices and cell adhesion.

  1985cited by this paper
• Molecular cloning of S‐protein, a link between complement, coagulation and cell‐substrate adhesion.

  1985cited by this paper
• Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin.

  1985cited by this paper
• The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.

  1985cited by this paper
• Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology

  1985cited by this paper
• The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.

  1985cited by this paper
• ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.

  1984influential reference
• Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion.

  1984influential reference
• Inhibition of von Willebrand factor–platelet interaction by fibrinogen

  1984cited by this paper
• Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

  1984cited by this paper
• Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.

  1984cited by this paper
• Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.

  1984cited by this paper
• Interaction of von Willebrand factor with human platelets in the plasma milieu.

  1984cited by this paper
• Molecular defects in interactions of platelets with the vessel wall.

  1984cited by this paper
• Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.

  1984cited by this paper
• Evidence that three adhesive proteins interact with a common recognition site on activated platelets.

  1984cited by this paper
• Characterization of calcium-dependent binding of endogenous factor VIII/von Willebrand factor to surface activated platelets.

  1984cited by this paper
• Von Willebrand factor has more than one binding site for platelets.

  1984cited by this paper
• Mechanism triggering platelet hemostatic plug formation in vivo.

  1984cited by this paper
• Platelet membrane glycoprotein I

  1984influential reference
• Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.

  1983cited by this paper
• Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.

  1983cited by this paper
• ROLE OF VON WILLEBRAND FACTOR IN PLATELET ADHESION TO THE SUBENDOTHELIUM

  1983cited by this paper
• Inhibition of platelet aggregation by fibronectin.

  1983cited by this paper
• Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.

  1983cited by this paper
• Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.

  1983cited by this paper
• Factor VIII/von Willebrand factor.

  1983cited by this paper
• Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment.

  1983cited by this paper
• Platelets have more than one binding site for von Willebrand factor.

  1983influential reference
• gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.

  1982cited by this paper
• Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.

  1982cited by this paper
• Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

  1982cited by this paper
• Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets.

  1982cited by this paper
• Radioimmunoassay of platelet factor 4.

  1982cited by this paper
• Adenosine diphosphate induces binding of von Willebrand factor to human platelets

  1982cited by this paper
• Identification of the fibrinogen receptor on human platelets by photoaffinity labeling.

  1982cited by this paper
• Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets.

  1981cited by this paper
• Human plasma fibronectin promotes the adhesion and spreading of platelets on surfaces coated with fibrillar collagen

  1981cited by this paper
• Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets.

  1980cited by this paper
• The effect of human fibronectin on platelet-collagen adhesion.

  1980cited by this paper
• Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendothelium

  1979cited by this paper
• Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha- granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor

  1979cited by this paper
• Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

  1979cited by this paper
• The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets.

  1979cited by this paper
• Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor.

  1979cited by this paper
• Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate.

  1979cited by this paper
• The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets.

  1979cited by this paper
• Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease.

  1978cited by this paper
• Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.

  1978cited by this paper
• Metabolism and Function of Human Platelets Washed by Albumin Density Gradient Separation

  1977cited by this paper
• Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man.

  1977cited by this paper
• Binding of soluble form of fibroblast surface protein, fibronectin, to collagen

  1977cited by this paper
• Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.

  1976cited by this paper
• Platelet retention in glass bead columns: adhesion to glass and subsequent platelet-platelet interactions.

  1976cited by this paper
• Platelets, Surfaces and Plasma Proteins in Platelet Adhesion

  1975cited by this paper
• Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+.

  1975cited by this paper
• Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis.

  1974cited by this paper
• Decreased adhesion of platelets to subendothelium in von Willebrand's disease.

  1974cited by this paper
• Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.

  1974cited by this paper
• Isolation of human platelets and platelet surface membranes.

  1974cited by this paper
• The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi.

  1973cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper
• Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia.

  1971influential reference
• The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

  1959cited by this paper

• Marginal Band Collapsing: Structural Insights Into Shear-Induced Platelet Activation Relevant to Circulatory Assist Devices.

  2026cites this paper
• A Biophysics-Based Mathematical Model of Shear-Induced Platelet Activation and Receptor Shedding: Re-Examining Previous Experimental Data.

  2025cites this paper
• Platelet and endothelial cell responses under concurrent shear stress and tensile strain.

  2023cites this paper
• A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD

  2022cites this paper
• In Vitro Measurement and Modeling of Platelet Adhesion on VWF-Coated Surfaces in Channel Flow.

  2019cites this paper
• Foreword: A Brief History of Ideas About Platelets in Health and Disease

  2019cites this paper
• Matrix by Nonpeptidic Mimetics of Arg-GIy-Asp

  2018cites this paper
• Management of Congenital Afibrinogenemia: Report of Two Cases

  2017cites this paper
• Zeroing in on red blood cell unit expiry

  2017cites this paper
• Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation

  2017cites this paper
• Platelet Biology in Utero-placental Disease

  2016influential citation
• Intercellular Interactions as Regulators of NETosis

  2016cites this paper
• Evaluation of antithrombotic effect: Importance of testing components and methodologies.

  2015cites this paper
• 4.17 – Biocompatible Coating

  2014cites this paper
• Shear-stress induced acquired von Willebrand syndrome in children with congenital heart disease.

  2014cites this paper
• Bisphosphonates and implants in the jaw bone

  2013cites this paper
• Chapter 20 – Platelet Thrombus Formation in Flowing Blood

  2013cites this paper
• A Brief History of Ideas About Platelets in Health and Disease

  2013cites this paper
• Willebrand factor interaction von - Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX

  2013cites this paper
• Age-related differences in thrombin generation using a mathematical model

  2013cites this paper
• Receptors and Adhesive Proteins Under Flow Aggregation Disorders: Distinct Shear-Dependent Roles of Platelet Real-Time Analysis of Mural Thrombus Formation in Various Platelet

  2013cites this paper
• Cardiac Surgery

  2012cites this paper
• Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.

  2011cites this paper
• Current issues with glycoprotein IIb-IIIa antagonists.

  2011cites this paper
• Principles of Cellular Engineering: Understanding the Biomolecular Interface

  2011cites this paper
• platelet cohesion process with surface-immobilized von Willebrand factor in a solid-phase Role and initiation mechanism of the interaction of glycoprotein Ib

  2011cites this paper
• Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.

  2011cites this paper
• Glanzmann's Thrombasthenia: An Overview

  2009cites this paper
• HEMODYNAMICS OF THROMBOSIS Thrombosis Under Flow and In Vivo Thrombi

  2009cites this paper
• Free oscillation rheometry in the assessment of platelet quality

  2008cites this paper
• Fibrinogen and von Willebrand factor mediated platelet adhesion to polystyrene under flow conditions

  2008cites this paper
• Animals Models in Restenosis The Pig Restenosis Model

  2008cites this paper
• Studies on subfractions of fibrinogen : With special emphasis on fibrinogen quantification, viscosity and inflammation

  2008cites this paper
• Role of cellular elements in thrombus formation and dissolution.

  2008cites this paper
• Blood flow devices in medical research and clinical testing in humans: are we approaching personalized medicine?

  2007cites this paper
• Role of CD36 in Platelet Function

  2007cites this paper
• CHAPTER 18 – Platelet Thrombus Formation in Flowing Blood

  2007cites this paper
• Multiple congenital coagulopathies co‐expressed with Von Willebrand’s disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature

  2007cites this paper
• The growing complexity of platelet aggregation.

  2007cites this paper
• Platelet integrins and immunoreceptors

  2007cites this paper
• Polymorphismus Phe/Tyr 2561 im Von-Willebrand-Faktor-Gen als Risikofaktor für Myokardinfarkt und koronare Herzkrankheit

  2006cites this paper
• Risk Stratification and Risk Modification in Patients with Acute Coronary Syndromes

  2006cites this paper
• Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.

  2006cites this paper
• DYNAMICS OF PLATELET AGGREGATION AND ADHESION TO REACTIVE SURFACES UNDER FLOW

  2006cites this paper
• PI 3-kinase p110β: a new target for antithrombotic therapy

  2005cites this paper
• Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions.

  2005cites this paper
• Mechanics of transient platelet adhesion to von Willebrand factor under flow.

  2005cites this paper
• Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions

  2005cites this paper
• Formation in Primates With Monoclonal Antibodies

  2005cites this paper
• Canine Model of Coronary Artery Thrombosis

  2005cites this paper
• Target for Antithrombotic Intervention

  2005cites this paper
• Novel antithrombotic strategies for the treatment of coronary artery thrombosis: A critical appraisal

  2005cites this paper
• PI 3-kinase p110beta: a new target for antithrombotic therapy.

  2005cites this paper
• Hyperfibrinogenemia Alone Does Not Affect the Patency of Microvascular Anastomosis: Clinical Experience and Animal Study

  2005cites this paper
• Pathophysiology of restenosis

  2004cites this paper
• Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen.

  2004cites this paper
• Characterization of the anti‐platelet actions of FK419, a novel non‐peptide antagonist of platelet GPIIb/IIIa

  2004cites this paper
• Anti-vWf Antibodies Induce GPIbα and FcγRII Mediated Platelet Aggregation Only at Low Shear Forces

  2004cites this paper
• Development of glycoprotein IIb–IIIa antagonists: translation of pharmacodynamic effects into clinical benefit

  2004cites this paper
• The effects of lipid-regulating therapy on haemostatic parameters.

  2003cites this paper
• Integrin alpha IIb beta 3-dependent calcium signals regulate platelet-fibrinogen interactions under flow. Involvement of phospholipase C gamma 2.

  2003cites this paper
• Intercellular calcium communication regulates platelet aggregation and thrombus growth

  2003cites this paper
• The effects of antihypertensive therapy on haemostatic parameters.

  2003cites this paper
• Signaling events underlying thrombus formation

  2003cites this paper
• Vortex-mediated Mechanical Stress Induces Integrin-dependent Cell Adhesion Mediated by Inositol 1,4,5-Trisphosphate-sensitive Ca2+ Release in THP-1 Cells*

  2003cites this paper
• Antiplatelet therapy: in search of the 'magic bullet'

  2003cites this paper
• Glycoprotein IIb/IIIa Antagonists

  2003cites this paper
• A novel von Willebrand factor binding protein expressed by Staphylococcus aureus.

  2002cites this paper
• Platelet-fibrin(ogen) interactions in flowing blood

  2002cites this paper
• The role of platelets in peripheral arterial disease: Therapeutic implications

  2002cites this paper
• The Role of von Willebrand Factor in Platelet Function

  2002cites this paper
• The management of von Willebrand's disease-associated gastrointestinal angiodysplasia

  2001cites this paper
• Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.

  2001cites this paper
• Absence of Fibrinogen in Afibrinogenemia Results in Large but Loosely Packed Thrombi under Flow Conditions

  2001cites this paper
• Two distinct mechanisms are involved in stent thrombosis under flow conditions.

  2001cites this paper
• Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy.

  2001cites this paper
• Maladie de Willebrand

  2001cites this paper
• Role of platelet glycoprotein IIb/IIIa in ADP‐activated platelet adhesion to aortic endothelial cells in vitro: observation with video‐enhanced contrast microscopy

  2001cites this paper
• Two distinct mechanisms are involved in stent thrombosis under flow conditions

  2001cites this paper
• Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa.

  2001cites this paper
• Anti-vWf antibodies induce GPIbalpha and FcgammaRII mediated platelet aggregation only at low shear forces.

  2001cites this paper
• Mechanisms of platelet aggregation.

  2001cites this paper
• Atomic force microscopy of biomaterials surfaces and interfaces

  2001cites this paper
• Uremic Medium Disturbs the Hemostatic Balance of Cultured Human Endothelial Cells

  2001cites this paper
• Red blood cell and platelet interactions with titanium implant surfaces.

  2000cites this paper
• Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction.

  2000cites this paper
• Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von willebrand factor interaction.

  2000cites this paper
• 血小板膜糖タンパク受容体 (インテグリン機構) の薬理学的意義 : 血管狭窄の制御および生体内新規抗血小板作用物質の同定

  2000cites this paper
• Severe and relapsing upper gastrointestinal bleeding in a patient with Glanzmann's thrombasthenia.

  2000cites this paper
• Adjuvant effect of antibodies against von Willebrand Factor, fibrinogen, and fibronectin on staphylokinase-induced thrombolysis as measured using mural thrombi formed in rat mesenteric venules.

  2000cites this paper
• Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

  2000cites this paper
• CASE REPORT: Severe and Relapsing Upper Gastrointestinal Bleeding in a Patient with Glanzmann's Thrombasthenia

  2000cites this paper
• Influence of vortex speed on fresh versus stored platelet aggregation in the absence and presence of extracellular ATP.

  2000cites this paper
• Hemorrhagic problems in obstetrics, exclusive of disseminated intravascular coagulation.

  2000cites this paper
• Platelet adhesion to human brain microvascular endothelial cells in vitro. Observation with video-enhanced contrast microscopy.

  1999cites this paper
• Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.

  1999cites this paper
• Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow.

  1999cites this paper
• A role for phosphatidylinositol 3-kinase in platelet aggregation

  1999cites this paper
• Prevention of Restenosis after Percutaneous Coronary Interventions: The Medical Approach

  1999cites this paper
• Platelet function and lipid-lowering interventions.

  1999cites this paper